Difference between revisions of "Aminopterin"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Discontinued" to "Category:Discontinued drugs") |
m |
||
| Line 12: | Line 12: | ||
[[Category:Antifolates]] | [[Category:Antifolates]] | ||
| − | [[Category:B-cell acute lymphoblastic leukemia medications]] | + | [[Category:B-cell acute lymphoblastic leukemia medications (historic)]] |
[[Category:Investigational drugs]] | [[Category:Investigational drugs]] | ||
[[Category:Discontinued drugs]] | [[Category:Discontinued drugs]] | ||
Revision as of 01:54, 26 April 2022
General information
Class/mechanism: Folate analog, antimetabolite, interferes with DNA synthesis. Discontinued due to concerns about toxicity, manufacturing difficulties, and rough equivalence to methotrexate. It remains under investigation for the non-neoplastic condition of psoriasis.
Route: IM